ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
17.57
+0.05 (0.29%)
Jan 17, 2025, 4:00 PM EST - Market closed
ACADIA Pharmaceuticals Revenue by Product
History
| Date | NUPLAZID | DAYBUE |
|---|---|---|
| Sep 30, 2024 | 590.42M | 338.78M |
| Jun 30, 2024 | 576.06M | 314.43M |
| Mar 31, 2024 | 560.67M | 253.10M |
| Dec 31, 2023 | 549.21M | 177.19M |
| Sep 30, 2023 | 541.81M | 90.09M |
| Jun 30, 2023 | 527.68M | 23.22M |
| Mar 31, 2023 | 520.26M | - |
| Dec 31, 2022 | 517.30M | - |
| Sep 30, 2022 | 511.60M | - |
| Jun 30, 2022 | 512.50M | - |
| Mar 31, 2022 | 493.10M | - |
| Dec 31, 2021 | 484.20M | - |
| Sep 30, 2021 | 474.40M | - |
| Jun 30, 2021 | 463.40M | - |
| Mar 31, 2021 | 458.30M | - |
| Dec 31, 2020 | 441.80M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.